Sign in

NCT05927974Recruiting

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

Source: ClinicalTrials.gov · Last updated 29 Apr 2026

Brief summary (registry, in English)

The purpose of this study is to investigate the brain activity associated with cognitive tasks (thinking, reasoning, remembering) in order to understand how the brain works during certain tasks and to improve treatment for diseases like dementia and attention deficit disorders. Cognitive (thinking) impairment may include poor memory function, poor attention span, or psychiatric disorders (ex: ADD, depression). The investigators are interested in the brain activity related to these issues, and want to investigate changes in brain activity while we record activity from specific areas of the brain. These recordings are in addition to clinical (routine or standard of care) recordings being performed to monitor for seizures and do not impact the clinical care.

Status (registry)
Recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
7 Jun 2023
Start date
27 Mar 2023
Primary completion date
27 Mar 2027
Lead sponsor
University of Alabama at Birmingham
Diseases
Epilepsy
NCT number
NCT05927974

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 27 Mar 2023 to the primary completion date, 27 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major medical or surgical complication

Age

  • Age younger than 18

Other

  • Inability to provide full and informed consent
  • Are not physically able to participate in study-related activities

Who the study is looking for

  • Eligible for surgery based on multi-disciplinary consensus review
  • Have a diagnosis of medically-refractory epilepsy
  • A minimum of 18 years of age
  • Willingness to participate in the paradigms described in the protocol

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.